ethidium and Ataxia
ethidium has been researched along with Ataxia in 1 studies
Ethidium: A trypanocidal agent and possible antiviral agent that is widely used in experimental cell biology and biochemistry. Ethidium has several experimentally useful properties including binding to nucleic acids, noncompetitive inhibition of nicotinic acetylcholine receptors, and fluorescence among others. It is most commonly used as the bromide.
ethidium : The fluorescent compound widely used in experimental cell biology and biochemistry to reveal double-stranded DNA and RNA.
Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pathological evidence of demyelination was observed in pontine tissue and higher levels of caspase-3 activity were detected compared to control rats." | 1.51 | LINGO-1 siRNA nanoparticles promote central remyelination in ethidium bromide-induced demyelination in rats. ( Abdelmonsif, DA; Dief, AE; El Azhary, NM; El-Fetiany, OS; Youssef, AEH, 2019) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Youssef, AEH | 1 |
| Dief, AE | 1 |
| El Azhary, NM | 1 |
| Abdelmonsif, DA | 1 |
| El-Fetiany, OS | 1 |
Other Studies
1 other study available for ethidium and Ataxia
| Article | Year |
|---|---|
LINGO-1 siRNA nanoparticles promote central remyelination in ethidium bromide-induced demyelination in rats.
Topics: Administration, Intranasal; Animals; Ataxia; Caspase 3; Chitosan; Demyelinating Diseases; Disease Mo | 2019 |